Methodology for user and user's life centered clinical evaluation of assistive technology (ULCEAT): Evaluation with prototype Roboticbed®.
Background: Clinical evaluation of novel assistive technologies is of utmost importance, as this would help in making such technologies practical and ensuring that they suit the user's requirements. Objective: The purpose of this study is to develop a new methodology for the addition of user and use...
| Publicado en: | Technology & Disability Vol. 24; no. 4; pp. 273 - 283 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | case study research tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Background: Clinical evaluation of novel assistive technologies is of utmost importance, as this would help in making such technologies practical and ensuring that they suit the user's requirements. Objective: The purpose of this study is to develop a new methodology for the addition of user and user's life centered clinical evaluation of assistive technologies (ULCEAT) to conventional evaluation methods. The proposed ULCEAT methodology consists of two steps: evaluation by rehabilitation professionals and evaluation by potential users. These evaluations were performed to identify target users and to ensure the effective use of new assistive technologies (ATs); the evaluations were based primarily on qualitative research involving the rehabilitation professionals and the potential users. Methods: The methodology was demonstrated by using it for the clinical evaluation of Roboticbed®, which was developed by the Panasonic Corporation. Results: The effective use of Roboticbed® was confirmed on the basis of the results, and three target user types were identified. The validity of this methodology was further confirmed by a user evaluation of Roboticbed® in an experimental environment. Conclusions: The findings of this study will be used to help conduct conventional clinical evaluations for novel and prototype ATs. |
|---|